Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada
T. Younis, A. Lee, M. E. Coombes, N. Bouganim, D. Becker, C. Revil, G. S. Jhuti
科研成果: 期刊稿件 › 文章 › 同行评审
7
引用
(Scopus)